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Abstract
Background: Pharmacy education and pharmacy practice are facing remarkable changes following new scientific
discoveries, evolving patient needs and the requirements of advanced pharmacy competency for practices. Many
countries are introducing or undertaking major transformations in pharmacy education. The Thai pharmacy curriculum
has been changed from a 5-year BPharm and a 6-year PharmD to only a 6-year PharmD programme. Curriculum
change processes usually involve stakeholders, including both internal and external educational institutions, at all
levels. This study aims to understand the experiences and perceptions of stakeholders regarding the transition to
an all-PharmD programme in Thailand.
Methods: Semi-structured interviews were conducted in Thailand with 130 stakeholders (e.g., policy makers,
pharmacy experts, educators, health care providers, patients, students and parents) from August-October 2013.
The interviews were audio recorded, transcribed verbatim and analysed using an inductive thematic analysis.
Results: Three main themes were derived from the findings: 1. influences on curriculum change (e.g., the needs
of pharmacists to provide better patient care, the US-Thai consortium for the development of pharmacy education); 2.
perceived benefits (e.g., improve pharmacy competencies from generalists to specialists, ready to work after
graduation, providing a high quality of patient care); and 3. concerns (e.g., the higher costs of study for a longer
period of time, the mismatch between the pharmacy graduates’ competency and the job market’s needs, insufficient
preceptors and training sites, lack of practical experience of the faculty members and issues related to the separate
licenses that are necessary due to the difference in the graduates’ specialties).
Conclusions: This is the first study to highlight the issues surrounding the transition to the 6-year PharmD programme
in Thailand, which was initiated due to the need for higher levels of competency among the nation’s pharmacists.
The transition was influenced by many factors. Many participants perceived benefits from the new pharmacy curriculum.
However, some participants were concerned about this transition. Although most of the respondents accepted the need
to go forward to the 6-year PharmD programme, designing an effective curriculum, providing a sufficient number of
qualified PharmD preceptors, determining certain competencies of pharmacists in different practices and monitoring the
quality of pharmacy education still need to be addressed during this transitional stage of pharmacy education in Thailand.
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Background
Pharmacy education and pharmacy practice are facing
remarkable changes following new scientific discoveries,
evolving patient needs and the requirements for advanced
pharmacy competency for current and future practices
[1, 2]. Therefore, many countries are introducing or under-
taking major transformations in pharmacy education [1, 2].
The World Health Organization (WHO), the United
Nations Educational, Scientific and Cultural Organisation
(UNESCO) and the International Pharmaceutical Feder-
ation Education Development Team (FIPEd) all aim to
improve global pharmacy education and have developed a
“needs-based education model” [1, 3–6]. The model stipu-
lates that pharmacy education programmes must be de-
signed to ensure that required competencies are achieved
by all pharmacy graduates to deliver pharmacy services
that meet the needs of national populations. Many coun-
tries have been upgrading their pharmacy degree pro-
grammes to the level of Doctor of Pharmacy (PharmD)
[7–13]. However, literature exploring the adoption of
such programmes in Asian countries is limited [14–16].
The initiation of modern pharmacy education in Thailand
began in 1913 with a 3-year programme which extended
to a 4-year programme in 1939 and then to a 5-year Bach-
elor in Pharmacy (BPharm) programme in 1957 [17–19].
In 1993, the US-Thai consortium for the development
of pharmacy education in Thailand was established [19].
Thai pharmacy educators and pharmacy practitioners par-
ticipated in this collaboration to develop the academic
workforce that was needed. In 1999, the first of the
Thai Doctor of Pharmacy (PharmD) programmes, which
focused on patient care at the Faculty of Pharmaceut-
ical Sciences, Naresuan University, was established
[18, 20–22]. The details of the history of all 6-year PharmD
programmes in Thailand are shown in Fig. 1 [17, 23–36].
From 1990–2010, the majority of Faculties of Pharmacy
in Thailand offered a 5-year BPharm programme. The
5-year programme was divided into three tracks: pharma-
ceutical sciences, pharmaceutical care and social and
administrative pharmacy; this allowed students to achieve
more professional specialisation [18, 23, 37]. However, the
new pharmacy graduates and employers felt that the
graduates were still inadequately trained and were not
prepared for post-graduation practice [28, 38].
Similar to other countries that were changing to an
Entry-Level PharmD (ELPD) programme [39–46], unified
support for the transition to an all- PharmD programme
was also limited in Thailand [39, 45]. Pramyothin et al.
[30] found that while most experts from hospitals and con-
sumer protection sectors agreed with a 6-year programme
with special tracks, advanced practitioners from the com-
munity pharmacy and industry areas preferred a 5-year
programme with special tracks. Wongpoowarak et al.
[47] found that most pharmacy graduates and employers
felt that a 6-year PharmD was needed for both tracks
(pharmaceutical care and pharmaceutical sciences);
they also reported that while academic staff had mixed
views regarding the appropriate duration of a pharmacy
Fig. 1 History of all 6-year PharmD programmes in Thailand
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programme in pharmaceutical sciences, the majority
(63 %) sided with 5 years as opposed 15 % and 22 %
who preferred 4 years and 6 years, respectively. An-
other study which carried out a survey of pharmacists
regarding curriculum changes found that most of the
respondents did not agree that a 6-year programme would
either decrease the pharmacy curriculum workload or im-
prove the status of pharmacists to reach that of medicine
and dentistry graduates (both also 6-year programmes).
Most respondents agreed that the pharmacy curriculum
should be producing generalists but that specialties should
be studied in higher education. The majority of the re-
spondents believed that the pharmacy curriculum should
include both 5- and 6-year options, while about 20 % of
respondents believed that only one the 6-year programme
should be offered [48, 49].
Thai policy makers believed that a complete transition
to the 6-year PharmD would meet the needs of the
stakeholders by changing pharmacy competencies from
generalists to specialists, resolve the issue of curriculum
overload for the high-credit 5-year BPharm programme,
and produce equal educational standards and outcomes and
for the pharmacy profession on a national level [28, 38]. The
Pharmacy Council of Thailand (PCT) announced that
the 6-year PharmD programme would be compulsory
for pharmacy licensure starting from year 2014 onwards;
the BPharm programme was not offered after 2010
[18, 28, 30, 37]. All new pharmacists have to graduate
from pharmacy schools accredited by the Pharmacy
Council, with a 6-year PharmD degree based on the
new 6-year curriculum, a move designed to provide a
more comprehensive curriculum and in-depth knowledge
and skills in each specific pharmacy area [17, 18, 37, 50].
The US PharmD programme, which focuses on patient
care, has been adjusted to meet the context of the Thai
health system. The new PharmD curriculum is divided
into two tracks, a Pharmaceutical Care-PharmD (PC-PD)
programme and an Industrial Pharmacy (formerly
Pharmaceutical Sciences)-PharmD (IP-PD) programme
[23, 37, 51–53]. It is still under discussion as to whether
another track, Social and Administrative Pharmacy (SAP),
should either be independent or included in the other two
tracks [18, 23]. Pharmacy students in some faculties will
select their specialty upon admission; in other faculties,
students select their speciality programmes in the fourth
year of the PharmD [37].
The transition has been implemented by a collaboration
among regulatory bodies (e.g., PCT and government) and
educational institutions [28]. However, debates and
questions have been put forth on social networks about
the need for a change to an all-PharmD programme in
Thailand [48, 49]; among the questions asked were: ‘How
would an all-PharmD programme produce graduates to
meet the needs of various areas of pharmacy practices in
Thailand’? ‘How to incorporate the diverse competencies
of two specialised areas (PC-PD and IP-PD) into one pro-
fessional license?’ [18, 22, 30, 48]. Additionally, the lim-
ited resources and capacities of academic and training
institutions in developing countries that are changing to a
PharmD programme have been discussed [5, 54].
Stakeholders are an important aspect of the “needs-
based model” comprised by FIPEd’s Global Quality As-
surance Framework because it is the stakeholders who
dictate local or national needs [2, 55]. For example, regula-
tory bodies, such as government and the Pharmacy Coun-
cil, are responsible for pharmacy practice. They have the
duty to protect the wellbeing of the public by assuring that
the pharmacy workforce receives appropriate education
and training to deliver a standard quality of services
[2]. Curriculum change involves and affects many stake-
holders, including both internal and external educational
institutions (e.g., students, faculty members, staff mem-
bers, administrators, employers, employees, patients and
the public) at different levels, different roles and also dif-
ferent expectations [2, 55–58]. As such, exploring the
stakeholders’ perspectives and experiences regarding this
transition is crucial. There has been very little evidence, to
date, of such attempts in Thailand. Qualitative research
can provide meaning and understanding and is ideally
suited to explore a little researched area [59, 60]. There-
fore, this paper reports on a qualitative study which was
aimed to understand the experiences and perceptions of
stakeholders regarding the transition to an all-PharmD
programme in Thailand.
Methods
This study was granted ethical approval from the Faculty
of Sciences, University of Nottingham and the ethics au-
thorities in Thailand (the Research Ethics Committee of
Ubon Ratchathani University and the Research Ethics
Committee of Buddhachinaraj Hospital). Semi-structured
interviews were conducted with 130 stakeholders in the
Thai language during 1 Aug - 20 Oct, 2013.
Triangulated data were collected from different type of
stakeholder categories via interviews across four different
regions (e.g., Central, North, North-East, and South) to
check and establish validity [61–63] and also include sub-
groups of each stakeholder category to further maximise
sample variation [62, 64] (e.g. both administrators and
non-administrators from educational institutions were
targeted). Stakeholders groups included policy makers,
pharmacy experts or representatives of the pharmacy
profession’s associations (e.g., public and private hos-
pital pharmacy, community pharmacy, industrial pharmacy,
public health and consumer protection, marketing phar-
macy), educators (e.g., public and private university),
practicing pharmacists from different settings (e.g., tertiary
hospital, community hospital, community pharmacy, private
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hospital, industrial pharmacy, consumer protection, phar-
macy marketing, research and development), health
care providers (doctors, nurses, pharmacy technicians),
patients, students and their parents as well as members
of the general population. Participants included those in-
volved in the quality assurance of pharmacy education ac-
cording to the FIP definition [2]. Consensus among the
main researchers (TC, CA, PW) was reached with regards
to the selection process and sampling of participants.
Table 1 lists the inclusion criteria.
Stakeholders who met the inclusion criteria and pro-
vided their consent for their interview data being included
in a PhD thesis and publications [65] were recruited and
interviewed using an interview guide (see Table 2). All
participants were sent a participant information sheet
explaining the study to them [59, 65]. The interview
guide was developed based on both the purpose of this
study and a literature review. Pilot interviews with two
academic staff members, two pharmacists, one nurse,
one doctor, one member of the general population and
two students were conducted to refine the interview
strategy. The pilot interviews were included in the data
analysis. Recruitment was conducted by purposive sam-
pling and snowball sampling. Sampling and data collection
was guided by emerging themes and continued until the
point of data saturation that was established when the in-
terviews did not yield any new or emerging themes [66]
and the depth and extent of data collection and data
analysis seemed sufficient to allow the researcher to tell
a reasonable story [67, 68]. The saturation was reached
with varying numbers of participant from each sub-group
of stakeholders. The depth and extent of data collection
depended on participants’ roles and involvement in phar-
macy education; for example, saturation was reached
with 20 academic members from three specialised area
(e.g. pharmaceutical care, pharmaceutical sciences and
social and administration pharmacy) and different type
of PharmD programmes offered (e.g. PC-PD, IP-PD),
with 5 doctors and 5 nurses who have different length
of experience of working with PharmD pharmacists, with
10 policy makers who had different roles from the Phar-
macy Council of Thailand and the Pharmacy Education
Consortium of Thailand, and with 7 students from public
and private universities. However, additional 1–2 partici-
pants from each subgroup of stakeholder were interviewed
to confirm the saturation of themes.
The interviews lasted between 45–60 min. All inter-
views were audio recorded with informed consent. The in-
terviews had two sections, an introduction and personal
background section (e.g., age, education, career, area of
expertise, year of current work experience) and questions
about their past and current experiences regarding the
transition to an all-PharmD programme. Characteristics
of the interviewees are given in Table 3. TC, a PhD
research student has been a university lecturer in clinical
pharmacy area at Ubon Ratchathani University, Thailand,
for the last ten years and has observed the changes in
pharmacy education; she has not been involved in influen-
cing the policy of the all-PharmD programme. TC inter-
viewed the participants in the setting of their choice
(usually their workplace). 124 interviews were conducted
face-to-face, five via telephone, and one was a Skype inter-
view. PY and SM are university associate professors in
Thailand. PY had been involved the transition period as
a deputy dean of an academic affair and now is a policy
maker of the PCT. SM has not been involved in influen-
cing the policy of the all-PharmD programme. BL and CA
are academic supervisors of TC who has not been in-
volved in the transition of an all-PharmD programme
in Thailand.
Audio recordings were transcribed verbatim in Thai
and were checked twice for accuracy with the recordings
by TC and one Thai pharmacist [69]. Transcripts were
sent back to the interviewees for them to read or modify
the transcript if necessary [59, 70]. However, the majority
of participants chose not to check the transcripts. The
transcripts were checked and confirmed the correctness
by ten requested interviewees [62]. Thai transcripts were
translated to English to comply with the required audit
trail [71] by a Thai researcher (TC), who is a PhD student
in the UK. The audit trail is an essential part of rigorous
qualitative study that will able to track how the data were
analysed and how themes were generated through inter-
views and interpreted to assess the trustworthiness of
the research [72]. Additionally, it was essential that the
transcripts be translated to English as CA, a non-Thai
researcher and a senior qualitative researcher was directly in-
volved in the analysis and coding processes [73]. Meaning-
based translation [74] from Thai to English was performed
by TC and had forward-blind backward translations process
[74] to check the correctness of the translation. Twenty Eng-
lish transcripts were checked against the Thai transcripts by
TC and a bilingual Thai-English pharmacy academic re-
searcher. Two translators reached consensus regarding the
English translation. Then, convenience blind backward
translations [74, 75] of English transcripts into Thai were
undertaken for 13 of the 130 transcripts (10 %) by the
fluent Thai-English bilingual speaker. This process was
performed to validate the translations and ensure no loss
of conceptual equivalence had taken place [76].
English transcripts were then analysed thematically using
NVivo qualitative data analysis software (QSR International
Pty Ltd., Version 10, 2012) [77]. This study used an induct-
ive (data-driven with themes emerging directly from the
data) thematic analysis approach [78] and was influenced
by the principle of grounded theory [59, 66, 79] (e.g., the
general explanation or theory development generated or
“grounded” in data from the views of participants who have
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Table 1 The inclusion criteria and the selection of participants [2, 65–75]
Stakeholder group Central North North-East South Total Roles and importance
in pharmacy education
Selection and recruitment Method of
involvement
1. Policy makers/regulatory
bodies (n=10)
-The Pharmacy Council
of Thailand (PCT) is the
regulatory body for
pharmacists in Thailand.
3 0 1 1 5 -The PCT has a role to protect and
maintain the wellbeing of the public
by maintaining standards and public
trust in pharmacy (e.g., setting
standards for conduct, ethics, and
competency, accrediting pharmacy
degree programmes and pharmacy
educational institutions, processing
licensure examination and registration).
They must assure that pharmacists
receive appropriate education and
training and are competent to
deliver services.
-Policy makers, who had or still have
roles in curriculum change ever since
the issue of an all-PharmD was raised in
1993, were invited by email or letter and
telephone at least one month prior to
the interview date.
-Eleven policy makers were invited to
participate; one policy maker from the
Pharmacy Council did not respond
within the timeframe of the study.
Interview
-The Pharmacy Education
Consortium of Thailand
(PECT) has seventeen
pharmacy educational
institution members
across Thailand.
1 1 3 0 5 -PECT aims to promote the
advancement of pharmacy
education, support the
pharmacy professional practice,
protect common interests among
members, facilitate pharmacy student
activities, and collaborative work with
other professional organisations
(e.g., PCT and Thai pharmacy
associations).
-PECT prepared a government
scholarship to support faculty
development and by 1993 PECT
signed the first bilateral collaboration
between US and Thai pharmacy
schools, the US-Thai Consortium for
the Development of Pharmacy
Education in Thailand. This consortium
opened opportunities for Thai
academic members and students
to be trained and study in the US.
2. Pharmacy experts (n=13)
-Pharmacy experts or
representatives of professional
pharmacy associations in
Thailand
-Hospital pharmacy
(from both public and
private hospitals)
-Community pharmacy
-Industrial pharmacy
1
2
3
0
0
0
1
1
0
1
0
0
3
3
3
Pharmacy experts and pharmacy
practitioners are able to determine the
competencies required to deliver the
services that meet the needs of
employers and customers.
-Pharmacy experts or representatives of
professional associations were identified
primarily through the public websites of
their organisations, selected by
researchers, and invited by email and
telephone at least one month prior to
the interview date.
-Experts or representatives from
pharmacy associations from five areas in
Thailand (e.g., the Association of Hospital
Interview
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Table 1 The inclusion criteria and the selection of participants [2, 65–75] (Continued)
-Public health and consumer
protection
-Marketing pharmacy
3
1
0
0
0
0
0
0
3
1
Pharmacy (Thailand), the Community
Pharmacy Association (Thailand), the Thai
Industrial Pharmacist Association, the
Marketing Pharmacy Association Thailand)
and the Thai Food and Drug Administration
(FDA) as well as law and consumer protection
area and experts from the Pharmaceutical
Association of Thailand, who were current
practitioners, well known and were accepted
by pharmacists in their professional practice
areas, were invited.
-Sixteen experts or representatives of
pharmacy organisations were invited to
participate in this study; three experts
(1 from a hospital, 1 from industry and 1
from marketing) did not respond within the
timeframe of the study. n=13)
3. Academic staff (n=25)
-Dean
-Deputy dean (academic/
professional development)
Ua1U2
2
1
U3
1
1
U4
1
1
U5
1
1
5
4
-Faculties of pharmacy and academic
members have responsibilities in
terms of the quality of education and
value of investment in higher education
for students and families. Faculty
members committed to lifelong learning
in their specialty and continuous
improvement of their teaching skills,
devote sufficient time to teaching along
with research, administrative or academic
services (e.g., clinical roles) and also have
a duty to develop learning opportunities
and encourage pharmacy students to
participate. Faculty staff have
influence on promoting learning
environments, demonstrate professional
responsibility, encourage and assist their
students to assume responsibility for
their learning and express concern
regarding student development.
-The criteria to select the universities were
based on the region of the university,
type of ownership, type of programme,
year established and feasibility of study.
-Five universities (four public and one private
university) were selected and invited and a
letter requesting permission to conduct
research with each faculty was sent to the
dean. All faculty granted permission to
conduct this research.
-Deans, deputy deans of academic affair
or deans in pharmacy professional development
and faculty members were invited.
-The details of the five faculties are as follows:
•U1 (public) used to offer BPharm and then
changed to PC-PD & IP-PD
•U2 (private) used to offer BPharm and then
changed to PC-PD & IP-PD
•U3 (public) offering PC-PD
•U4 (public) used to offer BPharm and then
changed to PC-PD
•U5 (public) used to offer BPharm and
PC-PD and then changed to PC-PD & IP-PD
-Interview
-Skypeb
-Telephone
interviewb
Academic staff
-Pharmaceutical care area
-Industrial pharmacy/pharmaceutical
sciences area
-Social and administrative
pharmacy area
1
2
1
2
1
1
2
1
2
1
1
1
6
5
5
4. Students (n=9) 3 1 3 2 9 Students and their families invest
finances and time to obtain a
pharmacy degree and aim to learn
within a pharmacy curriculum designed
to prepare them for the profession.
They have the right to expect that the
PharmD programme has been
sufficiently evaluated and meets the
standards outlined by the PCT which
-Inclusion criteria were students who were
currently studying in the final year of a
6-year PharmD programme because they
had experience with the new 6-year
PharmD programme or the students who
were studying in the 5th year if their
faculties did not have 6th year students
during this study period (Aug-Oct 2013).
Participation was voluntary.
-Interview
-Telephone
interview
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Table 1 The inclusion criteria and the selection of participants [2, 65–75] (Continued)
should able to prepare them for a
pharmacy professional career. Students
should expect that the pharmacy
curriculum is timely, practical and
provide essential knowledge and skills
for successful professional practice.
-Students were invited to participate by a
researcher at the cafeteria or library of their
faculty at least 1 day prior to an interview date.
5. Parents (n=4) 2 2 0 0 4 Parents play an important role in
students’ university life (e.g., parental
support in terms of facilitating personal,
social, and academic development and
finances). They are concerned about
the accreditation of institutions
for the mature development of their
children and preparing their children
for the profession.
-Inclusion criterion was a parent of the
student who was currently studying in the
final year of a 6-year PharmD programme.
-Researcher asked the students about the
possibility of contact their parents to
participate in this study.
-Most parents lived in other provinces.
Therefore, parents were invited and
interviewed by the researcher via telephone.
-Telephone
interview
6. Pharmacists (n=30)
-Tertiary hospital
(Three pharmacists are the
administrators)
-Community hospital
-Community pharmacy
-Private hospital
(One pharmacists is an
administrator)
-Industrial
-Public health and consumer
protection
-Marketing
-Research and development
2
0
2
1
1
0
2
0
3
0
0
0
0
0
0
0
4
4
2
1
0
2
0
2
2
0
1
0
1
0
0
0
11
4
5
2
2
2
2
2
Pharmacy experts and pharmacy
practitioners are able to determine
the competencies required to deliver
services that meet the needs of the
final user (e.g., patient, other health
care providers and public).
Health care providers (doctors, nurses,
pharmacists and pharmacy technicians),
students and their parents were contacted
directly at their workplace at least 1 day prior
to an interview date. However, the patients
(at two hospitals) and general population
(at local supermarkets in urban and rural
areas) were asked for their participation on
the actual interview date, due to employing
convenience sampling.
-Interview
7. Health care providers
(n=18)
-Physicians
(Three physicians are the
administrators)
-Nurses(Two nurses are the
administrators)
-Pharmacy technicians
1
2
2
1
2
0
5
2
2
0
0
1
7
6
5
The pharmacy profession has embraced
a patient-focused role and works closely
with other health care professionals. Health
care providers’ opinions are very important
for the development of the pharmacy
curriculum as multidisciplinary education,
especially in terms of advanced practice
experience or clinical clerkships, during
which pharmacy students are exposed to
other health care providers and learn how
to become a member of a team after they
graduate. In addition, health care
provider opinions will explain how other
health profession view the role of
pharmacists in health care teams.
Health care providers (doctors, nurses,
pharmacists and pharmacy technicians)
were invited directly at their workplace at
least 1 day prior to an interview date.
-Interview
8. Patients (n=14) from two
hospitals (tertiary care hospital
and community hospital)
-In-Patient Department, IPD (n=5)
-Out-Patient Department, OPD (n=9)
0
0
4
6
1
3
0
0
5
9
-Pharmacists work with patients to
ensure that they receive the best
outcomes from their medications.
-They are the final users of pharmacy
practitioners. Patients’ opinions are
important to improve the quality of
pharmacy services and enhance
-In-patients who had received pharmaceutical
services on the medical wards from PharmD
pharmacists within the last two weeks prior to
interview. The nurses were requested to
identify and invite patients who were willing to
participate. Interviews took place bed-side on
patients’ wards with respect for the privacy of
-Interview
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Table 1 The inclusion criteria and the selection of participants [2, 65–75] (Continued)
communication and expectations
between patients and pharmacists,
increase the quality of pharmacy
education and also improve the
accountability and transparency of
health care delivered to patients.
patients’ interviews.
-Out-patients at chronic disease clinics
(e.g., DM clinic, oncology clinic and warfarin
clinic), who had received counselling services
from PharmD pharmacists within the last three
months. To minimise the selection bias from
pharmacists, the patients had been selected by
the researcher via OPD card screening on the
visit day. If patients had pharmacy counselling
in the last three months, then the researcher
asked the pharmacist to invite patients to
participate during the lag interval, while those
patients were waiting to see their doctor or
waiting for their prescription. Interviews took
place in private counselling rooms.
9. General population (n=7)
-Taxi driver
-Merchant
-Government officer
- Non-governmental
organisation (NGO)
0
1
1
1
0
0
0
0
1
2
0
0
0
0
1
0
1
3
2
1
-The roles of pharmacists and pharmacy
education have changed. The perception
of the general public regarding this
change is important; for example, how
they perceive the new role of
pharmacists, the knowledge and skills
required of pharmacists to provide
better services for them, and whether
they trust the advice that they may
receive from pharmacists.
-Their opinions will help to determine
how the pharmacy profession and
education can improve public
understanding and perceptions of
pharmacists in the future.
General population at a local supermarket in
Bangkok (capital city), Ubon Ratchathani and
Songkhla province (outside the capital city).
-Interview
Total 40 28 48 14 130
a U=University, b participants were asked for verbal consent before skype interview or telephone interview
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Table 2 Interview guide
Questions
General/background information Personal information: education, work experience, age, area of expertise, year of current work
experience.
Feelings and attitude towards a 6-year
PharmD programme
How do you feel about the all-PharmD policy in Thailand?
Impact of curriculum change What will be the impact of the curriculum change on education, pharmacy practice and the health
care system?
Policy makers, pharmacy experts
and academic staff
-Historical series or process Please tell me about the history of PharmD curriculum development in Thailand.
-Reason for changing Why do Thai pharmacy education have to change to a 6-year PharmD curriculum?
Who/which other organisations support this policy and why?
How does the PharmD curriculum value/suit the context of Thailand?
(Probes: health care system, quality of patient care, pharmacists’ roles, law and regulation)
-Involvement Please tell me about your role and responsibility in changing the curriculum policy.
Please tell me about the influence or motivation (in general/for your contribution) for this change.
-Process of changing policy What are the differences between the new PharmD programme and previous programme (e.g.,
BPharm, a traditional PharmD programme)?
How will the new curriculum change?
Manner of enacting of change: policy/real practice
Process in which you are involved
Readiness, preparedness for this change
Key learning, key enablers, significant challenges/ barriers
What do you need in terms of support?
Pharmacy students Motivating factors to study pharmacy
Choice of faculty of pharmacy
Perceptions of the 6-year PharmD programme
Experience as a final year student in the new PharmD programme
Impact of curriculum change (on student and family/ pharmacy profession/ career image)
Future career ambitions and views of career development
Parents Perceptions of the 6-year PharmD programme
Parental support for their children’s education
Experience as a parent of a PharmD student Impact of curriculum change (on student and family/
pharmacy profession/ career image)
Future career ambitions and views of career development
Employers Perceptions of the 6-year PharmD programme
General expectation of PharmD graduates
Differences in competencies/duties between BPharm and PharmD pharmacists?
Satisfaction with BPharm and PharmD pharmacists in terms of competencies and pharmacy services
Expectations from pharmacists’ roles
Expectations from pharmacy education institutions/pharmacy curriculum
Impact of curriculum change (on student and family/ pharmacy profession/ career image)
Pharmacists Perceptions of an all-PharmD programme
What are the differences in terms of about competencies/duties between BPharm
and PharmD pharmacists?
Expectations of into the new curriculum and real work situation
How do you perceive about PharmD pharmacists in your workplace settings?
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experience with the process; while the researcher collects
data, they begin analysis and go back to the field to collect
more information until data saturation is achieved, used
constant comparison analysis and theoretical sampling to
maximise the variation of participants) [62, 64]. However,
this study aimed to understand and develop an explanation
regarding this transition, which differs from pure grounded
theory as grounded theory aims to build the theory [79].
The data analysis was undertaken with the following
steps [80]:
1. The analysis began after the first two interviews for
each stakeholder group were transcribed and
continued during and after data collection.
2. The first two English transcripts from each
stakeholder group were read and re-read to gain an
understanding of the interviewees’ perceptions and
experiences [59, 78] by two researchers (TC, CA).
They independently read transcripts carefully line-
by-line, noted possible codes within the transcript
hard copy, and then started to code and produce a
coding structure.
3. The coding structure was revised and further
developed [59]. The codes were compared and
discussed by two authors (TC, CA) [62, 81–85].
4. The coding process was started again for all
transcripts using the NVivo 10.0 software.
5. A constant comparative analysis (moving back
and forth between the identification of similarities
and differences among emerging categories)
approach was taken; for example, new
information that might add to the code was
constantly compared with previous codes or
categories or themes that it might fit, or it was
determined whether a new code or category
should be created. The emerging themes were
Table 2 Interview guide (Continued)
Are there any differences in competencies between PharmD and BPharm pharmacists?
What makes a PharmD pharmacist different from a BPharm pharmacist?
What is the barrier to move from the traditional pharmacy to advanced pharmacy practice?
How to across the barrier?
What do you expect from a PharmD pharmacist?
Preceptor roles
Specific questions for PharmD pharmacists
How often/ how many days a week do you intervene regarding patients’ medications?
How do PharmD pharmacists add value to patient care?
How do you think your patients think about you?
Are there any differences in competencies between PharmD and BPharm pharmacists?
Health care providers How often do you contact a PharmD pharmacist regarding patients’ medications?
How do you perceive PharmD pharmacists in your workplace settings?
Are there any differences in competencies between PharmD and BPharm pharmacists?
Are you satisfies with the pharmaceutical care services from PharmD pharmacists?
What is the barrier to move from traditional pharmacy to advanced pharmacy practice?
What do you want to suggest to improve PharmD services?
Perceptions of pharmacy curriculum change to a 6-year PharmD programme
Expectations of the new curriculum and pharmacy practices in real workplace situation
Suggestions about multidisciplinary education
Patients/ general public Please explain the services that you receive from your pharmacists?
How do you think about your pharmacist? Are you satisfied with the pharmaceutical care services?
What do you want to suggest about improving pharmacy services?
Do you know how long the pharmacy programme is?
How do you think that pharmacy education changes with a 6-year programme?
Closing questions Is there anything you would like to add about an all-PharmD programme?
Is there anything that concerns you about the interviews or that you would like to ask me before we
finish?
Would you like to check your transcript after the interview?
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Table 3 Descriptive characteristics of participants (n = 130)
Participants Policy
makers
Pharmacy
Experts
Educators Pharmacy
students
Parents Physicians Nurses Pharmacists Pharmacy
technicians
Patients General
public
Number of participants 10 13 25 9 4 7 6 30 5 14 7
Gender
Male 7 7 13 4 1 5 0 7 1 4 4
Female 3 6 12 5 3 2 6 23 4 10 3
Age group (years)
20-30 0 0 3 9 0 0 2 8 3 2 0
31-40 0 0 2 0 0 3 1 11 1 2 2
41-50 0 6 13 0 2 1 2 6 1 5 4
51-60 5 6 6 0 2 3 1 5 0 2 1
More than 60 5 1 1 0 0 0 0 0 0 3 0
Work experience (years)
less than 5 0 0 3 0 N/A 0 2 1 3 N/A N/A
5-10 0 0 0 0 N/A 2 0 15 1 N/A N/A
11-15 0 0 0 0 N/A 1 0 2 0 N/A N/A
16-20 0 2 8 0 N/A 0 1 4 1 N/A N/A
more than 20 10 11 14 0 N/A 4 3 8 0 N/A N/A
Working area (years)
-Hospital pharmacy
(tertiary care hospital,
public)
1 3 0 0 0 4 3 11 3 0 0
-Hospital pharmacy
(community hospital,
public)
0 1 0 0 0 3 3 4 2 0 0
-Hospital pharmacy
(private)
0 1 0 0 0 0 0 2 0 0 0
-Community pharmacy 0 3 0 0 0 0 0 5 0 0 0
-Industrial pharmacy 1 2 0 0 0 0 0 2 0 0 0
-Public health and
consumer protection
1 2 0 0 0 0 0 2 0 0 0
-Marketing pharmacy 0 1 0 0 0 0 0 2 0 0 0
-Research and
development
0 0 0 0 0 0 0 2 0 0 0
-Academic (pharmaceutical
care)
3 0 10 0 0 0 0 0 0 0 0
-Academic (Pharmaceutical
technology
4 0 10 0 0 0 0 0 0 0 0
-Academic (Social and
administrative pharmacy)
0 0 5 0 0 0 0 0 0 0 0
Highest education
1. Physician
-Doctor of Medicine (MD) 0 0 0 0 0 1 0 0 0 0 0
-MD, Diploma 0 0 0 0 0 2 0 0 0 0 0
-MD, Specialist 0 0 0 0 0 4 0 0 0 0 0
2. Nurse
-Bachelor of Nursing
Science
0 0 0 0 0 0 4 0 0 0 0
-Master of Nursing Science 0 0 0 0 0 0 2 0 0 0 0
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coded and constantly compared and contrasted
with other interviewees’ transcripts [86].
6. To establish the reliability or the stability of responses to
multiple coders of the dataset, this study used the inter-
coder agreement process. A draft code book was
developed. It was aimed at determining the agreement
of the coding in terms of code names and coded
passages. TC and CA independently coded another
two transcripts using a codebook and comparing
codes. They considered the agreement of coding for
these passages to be more than 80 % of coding [62].
7. TC read through all transcripts repeatedly and
coded them for analysis while a PhD supervisor
(CA) checked and revised the coded text [73].
8. Thematic analysis was carried out using the “One
Sheet of Paper, OSOP” mind map method to
ensure that all the codes extracted within each
theme were included and compared in the
analysis [59]. This process aimed to find a story
in the data, which involved reading through each
section of the data and making notes on a single sheet
of paper, and was used to ensure that all different
issues were raised by the coded extracts, along with
the relevant participant IDs [59, 87] (see Fig. 2). TA,
CA, and BY considered the development of broader
themes from the codes.
Transcript coding (the process by which a qualitative
analyst links specific codes to specific data segments or
the process of organising data) involved four steps as
follows:
1. In vivo coding or initial coding in-text indicates the
coding of special terms of participants. In vivo
codes help us to preserve interviewees’ meaning
regarding their perspectives or experiences in the
coding itself [67]
2. Open coding (concepts/categories or free codes/free
nodes in NVivo 10.0 software)
3. Axial coding (relationship between categories or tree
code or tree nodes in NVivo 10.0 software)
4. Selective coding (core categories or higher level of
concepts/themes) [83, 88]
This study took the preliminary analyses consisting of
themes back to six participants (e.g., two policy makers,
two academic staff members, experts from the consumer
protection area and industrial pharmacy), who would
share their views of the analyses [62] to triangulate the
data. They agreed on the accuracy and credibility of the
findings. The findings and data from different sources
[61–63] (e.g., government document, conference pro-
ceedings, unpublished reports, unpublished meeting mi-
nutes) were compared and contrasted; facts provided by
the participants were confirmed.
Results
The findings revealed three major themes regarding stake-
holders’ perceptions towards the transition to the 6-year
PharmD programme in Thailand: influences of an all-
PharmD programme in Thailand, perceived benefits and
concerns regarding the transition to an all-PharmD
programme.
Table 3 Descriptive characteristics of participants (n = 130) (Continued)
3. Pharmacist
-BPharm 0 2 0 0 0 0 0 11 0 0 0
-MPharm/ MSc 2 7 2 0 0 0 0 12 0 0 0
-PharmD 0 0 0 0 0 0 0 7 0 0 0
-PhD 8 3 17 0 0 0 0 0 0 0 0
-PharmD, Pharmacy
residency
0 0 3 0 0 0 0 0 0 0 0
-PharmD, Board specialties 0 1 3 0 0 0 0 0 0 0 0
4. Pharmacy technician
-Diploma of public health
(Pharmacy Technique)
0 0 0 0 0 0 0 0 4 0 0
-Bachelor 0 0 0 0 0 0 0 0 1 0 0
5. Patient, parent, public
-Less than secondary
education
0 0 0 0 0 0 0 0 0 5 1
-Secondary education/
vocational education
0 0 0 9 2 0 0 0 0 5 2
-Bachelor 0 0 0 0 2 0 0 0 0 4 3
-Higher than bachelor 0 0 0 0 0 0 0 0 0 0 1
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Table 4 Subthemes and supporting quotes within the theme “Influences of an all- PharmD policy”
Key theme: Influences of an all- PharmD policy
Subthemes Concepts Participantsa Example of supporting quotes
The needs for pharmacists to provide a better
standard of pharmacy services
Hospital pharmacists need in-depth
knowledge to provide a better of
patient care
PM9 “Hospital pharmacists should have the in-depth knowledge to
serve patients by doing more than dispensing medication,
so a PharmD in pharmaceutical care is the answer.” (PM 9)
Need more specialty due to
pharmacy graduates’ competencies
from the previous pharmacy
programme (a 5-year BPharm) were
too broad
AC1_PSc_U1,
AC14_SAP_U5,
AC22_D_U5, PM1, PM3,
PM5, PM8
“Policy makers believed that separate pharmacy specialty by have
separate curriculum and training will meet the social need rather
than general pharmacist.” (AC14_SAP_U5)
“They see the problem that our pharmacist was too generalised.
Employers thought graduates did not have in-depth knowledge
either in patient care or product focused.” (AC22_D_U5)
“Another reason was regard to the 5-yearr programme which
does not make us experts in medicines and patient care.” (PM1)
Need higher competencies AC3_PC_U4,
AC14_SAP_U5, PM1, PM8
“The reason is increasing competency which should have to separate
to two special tracts (PC-PD, IP-PD) with more practice training.” (AC14_SAP_U5)
Pharmacists’ roles involve in patient
care
AC8_PC_U4, PM1 “Now pharmacist’s roles are more involvement in patient care.” (AC8_PC_U4)
The global trend towards providing patient
care services
The global trend of patient care
services
PM1, PM7, PM8 “We considered the direction at an international level and
saw that the trend for developed countries was normally to
adapt a practice role that emphasised patient care. This might
be more suitable due to the PharmD programme giving us
higher competencies as pharmacists.” (PM1)
“Global trends are likely to come to specifically in
pharmaceutical care. This global trend needs a quality
pharmacy the other way around, one more heavily weighted
towards pharmaceutical care. Pharm care was requiring more
profound training for new pharmacists to be ready to work.” (PM7)
The Cooperation of four faculties of pharmacy
and the Bureau of Health Service System
Development, Ministry of Public Health (MoPH)
The Cooperation of four faculties of
pharmacy and the Bureau of Health
Service System Development,
Ministry of Public Health (MoPH)
PM1, PM9 “There were agreed and jointed investment between four
faculties of pharmacy and the Bureau of Health Service
System Development, Ministry of Public Health (MoPH).
It was an atmosphere of new learning.” (PM1)
The US-Thai consortium for the development of
pharmacy education in Thailand
A strong cooperative network of
PECT, and the US-Thai consortium for
the development of pharmacy
education in Thailand
AC3_PC_U4, AC4_PC_U3,
AC10_PSc_U5,
AC21_D_U5, AC22_D_U1,
EXP13_HOS, PM1, PM2,
PM10
“The administrator of faculty of pharmacy had been
visited the pharmacy school in the US.
They thought that they should have a clinical pharmacy focused programme
which this future direction of pharmacist.” (AC4_PC_U3)
“The PECT and Ministry of Public health were co-ordinate for US-Thai consortium.
We received idea from US and learn from them. Both academic and pharmacists
were train from US.” (AC10_PSc_U5)
“A 6-year PharmD programme was implemented by policy of the pharmacy council.
Literally, I think it was influenced from US-Thai consortium which they
(pharmacy council) had accepted concept from US quite a lot.” (AC21_D_U5)
“It started from PECT since 1996–1997 that we have Thai-US consortium which is a
subset of the project of pharmacy workforce development of MoPH.
PECT thought that change to a 6- year programme might be the way to
develop the pharmacy profession in Thailand as in a developed country.” (PM2)
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Table 4 Subthemes and supporting quotes within the theme “Influences of an all- PharmD policy” (Continued)
“The result of the consortium has had a great impact on Thai pharmacy
education and the Thai pharmacy profession.” (PM10)
The announcement of the the
Pharmacy Council of Thailand (PCT)
The announcement of the the
Pharmacy Council of Thailand (PCT)
AC21_D_U5, PM2, PM3,
EXP12_COM, EXP13_HOS
“The Pharmacy Council stated that if we did not provide a 6-year PharmD curriculum,
our students will not qualify to take the licensure examination. All faculties have to
adapt their programmes to 6 years, no matter whether it is pharmaceutical sciences
or pharmaceutical care.” (AC21_D_U5)
“This policy was commenced as law by the Pharmacy Council.” (PM2)
“If PCT did not announce as a regulation, this would never be ready, right?
It was very confused at that time. We needed someone to make
decisions for our future.” (PM3)
“The intention of the PCT was good. They proposed to clarify the position
of the pharmacy profession which might useful to our society and our profession.”
(EXP 13_HOS)
aAbbreviation
AC_PSc Academic member in pharmaceutical sciences area, AC_PC Academic member in pharmaceutical care area, AC_SAP Academic member in social and administrative pharmacy), AC_D Dean, EXP_HOS Expert in
hospital pharmacy, EXP_COM community pharmacy, EXP_PSc Expert in industrial pharmacy, EXP_PB Expert in public health and consumer protection, EXP_MP Expert in marketing pharmacy, N Nurse, PH_HOS Hospital
pharmacist, PH_COM community pharmacist, PH_IP Industrial pharmacist, PH_PB Pharmacist in public health and consumer protection, PH_MP Pharmacist in marketing pharmacy, PH_RD Pharmacist in Research and
development, PHY Physician, PM Policy maker, PTECH Pharmacy technician, PT_IPD Patient in In-Patient Department, PT_OPD Patient in Out-Patient Department, PUB Public/general population, ST Student, PR Parent,
U1 University1, U2 University2, U3 University3, U4 University4, U5 University5
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Theme 1: Influences of an all-PharmD policy 4
The most frequent influence of an all- PharmD policy
noted in the findings was the need for pharmacists to
provide a better standard of patient care due to the com-
petencies of pharmacy graduates from the previous phar-
macy programme (a 5-year BPharm) being too broad and
not being suitable for pharmacy practice in the patient
care area in Thailand. The detailed themes and subthemes
are presented in Fig. 3. The subthemes and supporting
quotes are presented in Table 4.
“Hospital pharmacists should have the in-depth
knowledge to serve patients by doing more than dis-
pensing medication, so a PharmD in pharmaceutical
care is the answer.” (Policy maker 9)
Policy makers who were involved in this transition
remembered the initiatives of this change as part of a
global trend towards providing patient care services.
“We considered the direction at an international level
and saw that the trend for developed countries was
normally to adapt a practice role that emphasised
patient care. This might be more suitable due to the
PharmD programme giving us higher competencies as
pharmacists.” (Policy maker 1)
A factor that has also been mentioned as an influ-
ence on the transition to an all-PharmD programme
was the Cooperation of four faculties of pharmacy and
the Bureau of Health Service System Development, Minis-
try of Public Health (MoPH), in the development and es-
tablishment of a master’s degree in clinical pharmacy
programme via a modular system. This foundation of
clinical pharmacy activities in real workplace settings
was supported by the US-Thai consortium for the devel-
opment of pharmacy education in Thailand (founded in
May 1994 by the Pharmacy Education Consortium of
Thailand, PECT).
Fig. 2 The process of theme development with the “One Sheet of Paper, OSOP” method
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“The result of the consortium has had a great impact
on Thai pharmacy education and the Thai pharmacy
profession.” (Policy maker 10)
The mission of this consortium was to provide Thai phar-
macy academic staff and pharmacists, who were selected by a
Royal Thai Government Panel, to access advanced profes-
sional (PharmD) or graduate (PhD) studies and training in se-
lected pharmacy schools in the US. Pharmacy educators
adopted the US PharmD programme to establish the first
Thai PharmD programme (pharmaceutical care) at the Fac-
ulty of Pharmaceutical Sciences, Naresuan University in 1999.
However, the big drive came from the announcement
of the Pharmacy Council of Thailand (PCT) in 2008
that, starting in 2014, all new pharmacy graduates would
have to graduate from pharmacy faculties accredited by
the Council through the 6-year PharmD curriculum only.
“The Pharmacy Council stated that if we did not
provide a 6-year PharmD curriculum, our students
will not qualify to take the licensure examination. All
faculties have to adapt their curriculum for all their
programmes to 6 years.” (Academic member 21)
Theme 2: Perceived benefits of the transition of pharmacy
education to an all-PharmD programme
Most interviewees from academic institutions and phar-
macy practitioners perceived benefits of the transition to an
all-PharmD programme because it was a step-up process
for pharmacy education and the profession and because it
enhanced a move from generalists to specialists, while grad-
uates’ users (e.g., patients, health care teams and employers)
perceived benefits as the PharmD graduates would have a
higher competency to meet their needs. The detailed
themes and subthemes are presented in Fig. 4. The sub-
themes and supporting quotes are presented in Table 5.
Step-up process
Thai pharmacy education has changed from the 5-year
BPharm degree (with three main tracks: PC, PSc, SAP)
and the 6-year PharmD degree focused on patient care
to a single national PharmD programme (offering both
pharmaceutical care (PC-PD) and industrial pharmacy
(IP-PD). Faculty members thought that this change was
a step up for the pharmacy profession and for pharmacy
education in Thailand.
Fig. 3 Theme “Influences of an all-PharmD policy”
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Table 5 Subthemes and supporting quotes within the theme “Perceived benefits”
Key theme: Perceived benefits
Subthemes Concepts Participantsa Example of supporting quotes
Step- up
process
Change from BPharm to PharmD
degree
AC4_PC_U3, AC19_PC_U3 “It was a step up from the Bachelor degree to the professional
degree which is a 6-year professional degree similar to other health
professions such as physicians and dentistry.”(AC 4_PC_U3)AC20_PC_U3
Increase reliability and improve
professional image
AC_D_U3, “This change might increase reliability to pharmacy
professional.”(PH2_HOS)
PH2_HOS, PH23_PB, PH21_IP, PH21_IP, PH13_MP, PH14_RD, PM1 “We should give the good services first so we will get trust from
public.” (PM1)
Higher salary than BPharm EXP9_HOS, EXP10_HOS, PH24_HOS, PH14_COM, PH18_COM, PR2, ST9 “The career progression of PharmD pharmacist is faster than a 5 year
programme. The 6-year PharmD graduates have higher salary than a
5 year pharmacist who works for 3–4 year before PharmD graduates.”
(EXP10_HOS)
“Career ladder is also good because a 6 year graduates had salary
which equivalence to a Master degree. Duration to higher position
is shorter than a 5 year BPharm.” (PH24_HOS)
Move from
generalists to
specialists
Chance to provide an advance pharmacy
practice
AC22_D_U2, AC25_U3, EXP9_HOS, PH20_IP, PH25_HOS, PM1 “A 5-year BPharm programme does not make us experts either in
medicines or patient care. This 6-year programme would give us higher
competencies.” (PM 1)
Increase skills and understanding for
working with teams
AC9_SAP_U1, N1, PH2_HOS, PH25_HOS, PHY5 “PharmD graduates had better skills in patient care. They had more
confident and work well with health care team.” (PH2_HOS)
Clear definition of pharmacists’ roles EXP13_HOS, PM1, PH2_HOS, ST8 “The intention of PCT was good. They proposed to clarify the position of
the pharmacy profession which might useful to our society and our
profession.” (EXP13_HOS)
“We see the clearer picture of patient care. It is a view, that this is
the direction we are going to do and the old curriculum was still
missing a lot of thing that we need to learn.” (PM1)
“Pharmacy professional will be looked clearer from this
pharmaceutical care.” (PH2_HOS)
Improve competency from general to
specialist
AC3_PC_U4, AC21_D_U5, AC22_D_U1, EXP2_COM, EXP9_HOS, EXP10_HOS,
EXP11_MP EXP13_HOS, PH24_HOS, PHY1, PHY4, PM1, PM2, PR1, ST1, ST6, ST7
“Pharmacist should prepare for specialty as well so they can work as
a health care team and easy to communicate.” (PHY4)
Right direction of pharmacy profession EXP9_HOS, PH23_PB, PH24_HOS, EXP13_HOS, AC13_PC_U1 “It is the right way and it was partial success. I give credit to
everyone. Everyone has good intention but it will be sustained or
not.” (AC13_PC_U1)
No more duck PH19_RD, PH22_HOS, PM1, ST3, ST4, ST5 “A 5-year BPharm programme does not make us experts either in medicinal
products or patient care. This 6-year programme would give us higher
competencies.” (PM1)
“We are too broad, like a duck. We should good at something
better than know everything, but we are not good in anything.”
(ST3)
Open new markets in pharmaceutical
sciences
AC17_SAP_U1, PH29_COM, PH30_COM, PM5, PM8 “Job markets are still available but we have to open new markets, such
as areas in vaccines, blood substitutes, nanotechnology, in herbal
medicine. Faculty should move to design our graduates.” (PM5)
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Table 5 Subthemes and supporting quotes within the theme “Perceived benefits” (Continued)
Meet the need
of stakeholders
Patients and population: better care for
patient
AC3_PC_U4, AC5_SAP_U1, N1, N2 PHY5, PHY7, PH2_HOS, PH15_COM,
PH16_COM, PH14_MP, PM9, PT_IPD4, PT_OPD2, PT_OPD6, PT_TECH1,
PT_TECH2, PUB2, PUB5
“PharmD graduates have better skills in patient care. They are more
confident and work well with health care teams.” (PH2_HOS)
“Employers from hospitals and community pharmacies had high
satisfaction with PharmD graduates.” (PM9)
“For the 6-year Pharmacy programme,
I think it must be good. I know that if patients have problems with
medicine they can talk with a pharmacist and the pharmacist will
talk to the doctor for them. It makes for better care for us.”
(PT_OPD2)
Patients and population: need
pharmacist to talk about their
medicines
PT_IPD2, PT_IPD4, PT_TECH4, PT_TECH5 “Pharmacist told us about how many tablets
we have to take or what the medicines used for. But I think it is not
enough. They should tell us more about how to monitor other
symptom s which might happen or how to monitor about side
effect.” (PT_IPD4)
Patients and population: pharmacists
are able to create the better world
PUB7, PUB3 “I am glad to know that some faculties encouraged their pharmacy
students to visit homes in poor community and help people about drug
related problems. Students should know about suffering in people’s life
who did not know their right to accessible to health care system.
Pharmacy professional had impact on society and pharmacists are able
to create the better world.” (PUB7)
Patients and population & Health care
teams: PharmD graduates provided
good services
EXP2_COM, N3, N5, N6, PHY2, PHY6, PT_IPD1, PT_IPD3, PT_IPD4,
PT_IPD5, PT_OPD1, PT_OPD2, PT_OPD3, PT_OPD4, PT_OPD5, PT_OPD6,
PT_OPD7, PT_OPD8, PT_OPD9, PT_TECH3, PUB1, PUB3, PUB4
“The 6-year pharmacists help us to adjusted doses, increase patients’
compliance and follow-up drugs ‘side effects.” (PHY2)
“I think it is good to have a pharmacist on ward. We discuss and
shared opinions which is beneficial for our patients.” (PHY6)
“They (PharmD graduates) explained very well. They told me about
diet, exercise and medicines.” (PT_OPD1)
“Her (PharmD graduates) service is very good. She takes a good care
to patients. I feel courage and able to talk with her. She makes us
feel warm. She is willing to treat us. I feel confident in her
knowledge for 100 percent sure.” (PT_OPD2)
“Pharmacist taught me how to use this medicine. I have to remove it
from the sealed pouch, peel off this, and clean the skin that the patch will
be applied. Pharmacist also told me that this medicine will have side
effect.”(PT_OPD5)
“The 6 year graduates are very important team member especially
in medicinal wards and ICU.” (N3)
Meet the need
of stakeholders
(continued)
Employers: ready to work AC6_SAP_U4, EXP3_HOS, EXP9_HOS, EXP10_HOS, EXP8_PB, PH2_HOS,
PH10_HOS, PH24_HOS, PH25_HOS, PH16_COM
“PharmD graduates are ready to work. It fulfil the need of
employers” (AC6)
“The 6-year PharmD programme is a perfect package. There was a
significant different in the competency of patient care between
PharmD and BPharm. I will choose a six year programme graduate
because they are ready to use.” (EXP9_HOS)
“PharmD graduates have the skills to approach other health care
providers. They are ready to work after graduation.” (EXP10_HOS)
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Table 5 Subthemes and supporting quotes within the theme “Perceived benefits” (Continued)
Policy makers and educators: solve
curriculum overload
AC2_PC_U4, PH2_HOS, PM5 “I think the 6- year PharmD programme is good because I
graduated from a 5-year programme which was too tight and
clerkship period is too short.” (PH2_HOS)
“The previous programme had curriculum overload but still lack of
skill. Policy makers discussed about this issue that if we change to a
6 year curriculum, this will provide more time to practice.” (PM5)
Students and parents: worth for
student’ life and career
PH25_HOS, PR1, PR3, PR4, ST2 “I think it is worth another year. It is an opportunity to choose the
way of life from the internship experience. Learning a six year
programme made the longer internship and had much more
experiences.” (PH25_HOS)
“The 6-year programme provides more practice and includes
additional things to learn.” (PR1)
“I think the-6 year programme is worth. We can expose the real
situation. In the sixth year we had clerkship all year. It is very useful
that we can learn a lot from training.” (ST 2)
Patients and population: increases
study period will produce pharmacist
who provide better care for patient
PHY5, PH26_HOS, PM8, PTECH3, PT_IPD4, PT_IPD5, PT_OPD6, PUB6 “The time for practicing in previous programme was too short and
had too much type of training sites.” (PM8)
Contrast view
“I think all pharmacists have high competence. There was no
different between a 5-year and 6-year graduates. They did not have
a different job description. They are working together.” (PTECH3)
Policy makers and educators: improve
readiness and preparedness in Pharm
care tract
AC1_PSc_U1, AC2_PC_U4, EXP9_HOS, EXP13_HOS, PH9_HOS,
PH25_HOS
“It will be very useful toward preparing the student for their work. A
5-year programme provided only 3 months of training rotation.
They have not enough time to practice.” (EXP 13_HOS)
“PharmD graduates had better skills in patient care. They had more
confident and work well with health care team.” (PH9_HOS)
Meet the need
of stakeholders
(continued)
Health care teams: Increase skills and
opportunity to understand and work as
health care team
AC4_PC_U4, AC18_PC_U3, AC19_PC_U3, EXP11_MR, N1, PH10_HOS,
PH25_HOS, PHY5, PTECH1, EXP11_MP
“The 6-year pharmacy graduates have higher knowledge. Their
views or critical thinking seem wider or have more understanding
about the concept of a multidisciplinary team. We are friends who
will walk together.” (N1)
“We extend to six year in order to do more work with patient. We
had the opportunity to work with doctors and nurses. When we
work with team, I felt that I am valuable. Dispensing is limiting our
potential. We used fully potential when we work on
ward.”(PH25_HOS)
“We work as health care team. Doctors cannot work by themselves.
The processes need other profession to take care and check.
Pharmacists help physicians about medicines. That is a confirmation
process for the best care to our patients.” (PHY5)
“The six-year graduates have more in-depth knowledge.” (PTECH1)
Policy makers and educators: provide
the same standard of curriculum
AC22_D_U1, EXP13, PM3, PM8 “At that time our country had both 5-year programme and 6-year
programme that might have some confusion in term of the
difference of certified of degree and salary of graduates.”
(AC22_D_U1)
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Table 5 Subthemes and supporting quotes within the theme “Perceived benefits” (Continued)
“They all have to be graduates of the six-year programme and
managed in a similar manner.” (PM 3)
Health care teams: increase skills in
home health care and holistic care
EXP12_COM, PH4_HOS, PH5_HOS, PH25_HOS, PH26_HOS, PH27_HOS,
PHY3
The six-year graduates provide home health care service and follow
up patient at home. They work like a family medicine but they are
family pharmacist. They had been added this skill. In the past, they
manage only medicine, but now they provide holistic care to
patients. (PHY3)
Health care teams: need specialised
pharmacist for teams
EXP3_HOS, EXP8_PB, PH11_HOS, PH28_HOS, PHY4, N4, N6 “Pharmacist should prepare for specialty as well so they can work as
a health care team and easy to communicate.” (PHY4)
Policy makers and educators: suit with
National service plan
AC3_PC_U4, EXP9_HOS, PH7_HOS, PH8_HOS, PH12_HOS “The 6-year programme follows context of national policy towards
health care and services excellence in Asia pacific. The National
service plan also encourage the developing of pharmacy services in
all level of care.” (AC3_PC_U4)
aAbbreviation
AC_PSc Academic member in pharmaceutical sciences area, AC_PC Academic member in pharmaceutical care area, AC_SAP Academic member in social and administrative pharmacy), AC_D Dean, EXP_HOS Expert in
hospital pharmacy, EXP_COM community pharmacy, EXP_PSc Expert in industrial pharmacy, EXP_PB Expert in public health and consumer protection, EXP_MP Expert in marketing pharmacy, N Nurse, PH_HOS Hospital
pharmacist, PH_COM community pharmacist, PH_IP Industrial pharmacist, PH_PB Pharmacist in public health and consumer protection, PH_MP Pharmacist in marketing pharmacy, PH_RD Pharmacist in Research and
development, PHY Physician, PM Policy maker, PTECH Pharmacy technician, PT_IPD Patient in In-Patient Department, PT_OPD Patient in Out-Patient Department, PUB Public/general population, ST Student, PR Parent,
U1 University1, U2 University2, U3 University3, U4 University4, U5 University5
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“It was a step up from the Bachelor degree to the
professional degree, which is a 6-year professional
degree similar to other health professions such as
physicians and dentistry.” (Academic member 4)
Unfortunately the Thai government originally gave the
PharmD the same status as a bachelor degree due to it
being an entry level programme, but they later rewarded
progression by matching the promotions and salaries of
PharmD graduates similar to those with a master’s de-
gree. Other 6-year programmes that have also been awarded
similar to a master’s degree include the Doctor of Medicine
(MD), Doctor of Dental Surgery (DDS) and Doctor of
Veterinary Medicine (DVM) in Thailand.
Move from generalists to specialists
The direction of pharmacy education in Thailand was not
clear before the transition process. After the pharmacy
council announced the all-PharmD policy, there were ef-
forts to equip existing pharmacists with specialised com-
petencies. Most interviewees thought that the transition
to the 6-year programme would improve pharmacy com-
petencies from generalists to advance general pharmacists
or specialists. The frequent phrase noted in the findings
was “the Thai pharmacist should not be a duck anymore”.
The Thai meaning of duck is that this bird is able to per-
form many tasks (e.g., flying, running and swimming) but
does not excel in any of them.
“We are too broad, like a duck. We should be good at
something better than knowing everything, but we are
not good in anything.” (PharmD Student 3)
“A 5-year BPharm programme does not make us
experts either in medicinal products or patient care.
This 6-year programme would give us higher competencies.”
(Policy maker 1)
However, some experts and academic members perceived
that the specialisation in the 6-year PharmD graduates
might suit only in patient care area rather than other
areas (e.g., industrial pharmacy, pharmacy marketing).
Meet the needs of the stakeholders
The minimum credit requirement for the 5-year BPharm
programme was 150, whereas the 6-year PharmD
programme requires a minimum of 220 credits. The
6-year PharmD programme requires 2,000 h of practice
training, which is 1,500 h more compared to the 5-year
BPharm programme. The increased credits in the 6-year
PharmD curriculum provide in-depth knowledge within
special tracks. The one-year extension provides the PharmD
students with more practice rotations. The stakeholders ex-
pect the PharmD graduates to have higher competencies and
be ready to work as pharmacists due to the greater number
of didactic credits and the longer training experience.
“The 6-year programme provides more practice and
includes additional things to learn.” (Parent 1)
The majority of pharmacists who work in pharmaceutical
care areas perceived the benefits of the PharmD
programme, such as preparing PharmD graduates for work
immediately after graduation, understanding other health
care professionals, and providing high quality patient care.
Fig. 4 Theme “Perceived benefits”
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Table 6 Subthemes and supporting quotes within the theme “Concerns”
Key theme: Concerns
Subthemes Concepts Participantsa Example of supporting quotes
Higher cost of study and value Cost of education to parents and the
government budget
AC12_SAP_U4, EXP4_PSc, PR1, PR3, ST1 “The negative effect is the cost of education to parents and the
government budget of at least six hundred million baht
(£12,253,000 or $18,421,000) a year, without being able to see
the benefit in the short or long term. Improving pharmacists’
competencies is a great thing but we have many ways to
improve them, such as, via studying or working in real life
situations.” (AC12_SAP_U4)
“A 5 yr programme will not increase cost. This increasing cost
gave a burden to the government, students and users or
employers due to when we had longer period of study, we will
ask higher rate of salary in both public and private sector.”
(EXP4_PSc)
“I think the cost is quite heavy. In case where we do not have
money, this might be a problem.” (PR 1)
“The cost is not much harder because he (her son) helps himself.
He got a scholarship from the faculty and works part-time job
with his teacher. When he comes back home, he rarely asks for
money. He needs only approximately 5,000 baht (£100 or $150)
per month. He is a very good saver. He rarely buys new clothes.”
(PR 3)
“The Pharmacy Council should prepare salary or compensation
for our degree. I heard that they increased our salary by only
1,000 baht (£20 or $31) a month compared to the 5 year
programme. It is not worth it to study another one year, when
we have to spend approximately 100,000 baht (£2042 or $3070)
for this extended year. There should be other ways to encourage
us to work hard and deserve our salary.” (ST1)
Real experience worth than training AC2_PC_U4, AC7_PSc_U4, AC12_SAP_U4 “I think about the difference between a 6th year pharmacy student
who has clerkship with an unprepared preceptor for one year
and a 5- year pharmacist who works for one year. They should
have different levels of maturity.” (AC12_SAP_U4)
Higher cost of study and its’
value (continued)
Wasting time and lost opportunity AC11_PSc_U5, AC12_SAP_U4, EXP4_PSc “IP-PD student study for 6 year in laboratory and train for R&D
but they work in community pharmacy due to the higher salary.
They did not use their knowledge and their specialty. It wasted
their time and opportunity to work because they have to study
and training for one more year instead of working,”
(AC11_PSc_U5)
“Improving pharmacist’s competency is a great thing but we
have many ways to improve it, such as, via studying or working
in real life situation. I did not see the benefit of the extended for
one year or the worth of this change. Why it should not be
Master degree instead of bachelor degree. Parents have to
support cost for another year and social lost pharmacist for
another year.” (AC12_SAP_U4)
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Table 6 Subthemes and supporting quotes within the theme “Concerns” (Continued)
“They loss opportunity to work. If they graduate in five year, they
will work faster for 1 year.” (EXP4_PSc)
A 5-year programme still need in
some areas
EXP4_PSc, EXP10_HOS, PM10, PHY7 “A 5-year programme in Pharmaceutical had enough and
appropriate basic knowledge to work as pharmacy
professional.”(EXP4_PSc)
“I think they are suitable to work in hospital setting but detailer
might not need 6 years or production line in hospital might
need a 5 year programme.” (EXP10_HOS)
“I want it to be a voluntary PharmD, rather than all six year
PharmD. Who want to learn six year, they can learn. Five year
curriculum is also need.” (PM10)
“I think the 6 year programme probably too much due to their
services might not need to study for 6 years. Most of them
might not work with patient in the hospital. Some pharmacists
work at community pharmacy that might need the different
competencies.” (PHY7)
Thai context different from the US
context
AC16_SAP_U2, PM2, PM9, PM10 “I do not see the benefit of the extended one year or the worth
of this change. Why should it not be a master’s degree instead
of a bachelor degree? Parents have to support the cost for
another year and society has lost a pharmacist for another
year.” (AC16_SAP_U2)
“We are not prosperous but we are not very poor either. We
should undertake appropriate education. The issue is that we
would like to follow the western model. We can find our own
way. I do not think six years is the best study programme in the
world.” (PM10)
Mismatch between the
pharmacy graduates’
competencies and the
requirements of the job
market
Mismatch competency and market’
needs within pharmaceutical care tract
(e.g. hospital and community
pharmacy settings)
EXP1_COM, EXP2_COM “In the past, the basic skill of Thai pharmacist is able to work as
a community pharmacist. Now, the responsibility of community
pharmacy had totally changed. Within PC-PD programme, it
should be separated into hospital pharmacist and community
pharmacist because they have different required competencies.”
(EXP 1_COM)
“Some faculties taught their PC-PD graduates that they should
work in hospitals only. Students told me that they were not
interested in community pharmacy but came here because it is
only a compulsory rotation.” (EXP2_COM)
Mismatch competency and market’
needs within industrial pharmacy tract
AC10_PSc_U5, AC11_PSc_U5, EXP1_COM, EXP5_COM, PM9 “The private sector hired graduates from other other areas such
as scientists who have a PhD degree. If you compare
pharmacists who have a bachelor’s degree and scientists who
have a PhD. pharmaceutical companies need PhDs more than
pharmacists because they have more experience in R&D”
(AC10_PSc_U5)
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Table 6 Subthemes and supporting quotes within the theme “Concerns” (Continued)
“Most of the pharm sciences students worked in community
pharmacies because they got higher salaries than industrial
plants but they were not well trained.” (AC11_PSc_U5)
“PSc-PD graduates should not do practice in community
pharmacies unless they have been passed the training and
gained skills and competency to qualify to work as community
pharmacist.” (EXP1_COM)
Although IP-PD graduates can work in other services such as
community pharmacy but they can work in certain levels. It will
be difficult when they work in advanced services. Community
pharmacy career is improved the services. It will provide the
services to chronic and complex diseases patients. IP-PD
graduates will struggle." (PM9)
Number of IP-PD was higher than job
market needed
AC1_PSc_U1, PC10_PSc_U5, AC13_PC_U4, AC21_D_U5,
AC22_D_U1, PM7, PM9
“The number of IP-PD students was higher than job market
need. I knew the job market. I feel empathy for students.”
(AC1_PSc_U1)
“There is limited job position in pharmaceutical industrial. They
need only 200 pharmacists per year. However, it still has
pharmacy shortage. I do not know the reason why graduates
do not want to work in industrial." (PM7)
“The number of pharm sc graduates should be reduced.“ (PM9)
Mismatch between the
pharmacy graduates’
competencies and the
requirements of the job
market.
Capacity of production depends on
supply side
AC1_PSc_U1, AC15_PSc_U2, AC21_D_U5, PH1_HOS, PM4,
PM_6, PM9
“This is problem in a level of policy. We might not base on
principles of market demand.” (AC1_PSc_U1)
“We have a readiness and preparedness in industrial pharmacy
more than clinical pharmacy so we have the number of IP-PD
more than PC-PD.”(AC15_PSc_U2)
“Basically, our basic structure is mainly in pharmaceutical
sciences area. Number of pharmaceutical sciences academic
staff higher than Pharm care staff. So, we have high number of
student in IP-PD tract because we have to consider about
education management.” (AC21_D_U5)
IP-PD graduates have a competitor in
the job market
AC11_PSc_U5, EXP7_PB, PM7 “Pharmaceutical company need PhD more than pharmacist
because they had more experience in R&D.” (AC11_PSc_U5)
(Note: PharmD degree in Thailand equivalent to Bachelor
degree)
“The opportunity of the 6-year IP-PD students would be less
because manufacturers might hire a 4-year scientist instead. It
might save cost for manufacturers. Pharmacist will have
competitor in the job market.” (EXP7_PB)
Need more communication “I feel uncomfortable about this change. It needed more
consideration before creating this new curriculum. It needed
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Table 6 Subthemes and supporting quotes within the theme “Concerns” (Continued)
AC1_PSc_U1, AC3_PC_U4, AC9_SAP_U1, AC12_SAP_U4,
AC13_PC_U1, AC21_D_U5, AC22_D_U1, EXP4_PSc, EXP5_PSc,
PM1, PM4, PM5, PM10, ST1
communication to answer questions such as the necessity for
change, the direction of change, and the main barrier that
should be considered.” (AC13_PC_U1)
“There was confused about Pharmaceutical sciences. What is
their scope and competency? Someone said all work which is
non-pharm care is pharm sciences. We have to discuss about
their competencies, regarding to the need of users.” (EXP5_PSc)
“It's a top down policy of the powerful people at that time. It
should have more serious consideration of views or listening to
each other.” (PM10)
Lack of resources Too quick and not ready AC1_PSc_U1, AC2_PC_U4, AC3_PC_U4, AC10_PSc_U5,
AC12_SAP_U4, AC15_PSc_U2, AC21_D_U5, EXP5_PSc, PM2
“Everything was move too fast. Even policy is suite for the future
but we have no personnel to serve the policy. We should
prepare PharmD preceptors then change to an entry level
PharmD.”(AC3_PC_U4)
“There was many problems such as preceptors were not ready,
academic staff also were not ready.” (EXP5_PSc)
Contrast view
“We have been informed about this change for many years
before the PCT announced.”(AC15_PSc_U2)
“It seems like question of “Which came first the chicken or the
egg?” If preceptors are not ready, we should train them. If
preceptor is not enough, we have to increase the number of
preceptor.” (PM2)
Lack of preceptors and training sites AC2_PC_U4, AC5_SAP_U1, AC9_SAP_U1, AC10_PSc_U5,
AC13_PC_U1, AC18_PC_U3, AC19_PC_U3, AC20_PC_U3,
AC22_D_U1, EXP3_HOS, EXP4_IP, EXP5_IP, EXP7_PB, EXP8_PB,
EXP9_HOS, EXP12_COM, PH3_HOS, PH9_HOS, PH6_HOS,
PH7_HOS, PH10_HOS, PH11_HOS, PH12_HOS, PH15_COM,
PH16_COM, PH20_IP, PH21_IP, PH24_HOS, PH25_HOS, PM3,
PM4, PM9, PM10
“We have to have our own staff to teach our students at
practice sites because pharmacists have high workload. We
have MOU with hospitals and have a great support from both
faculty and hospital administrators.” (AC5_SAP_U1)
“It increases the load of preceptors, of which they are still the
same number. Every faculty is competing.” (AC22_D_U1)
“Increasing to the 6-year programme and release students out
into the real world to find experience for themselves is not the
right way. Lecturers or master’s degree students should be
trained and transfer their experience to students. At least 20
students will be trained at each site, but the site employs only
one pharmacist.” (PM4)
Plan to develop preceptors and
teacher practitioners
AC3_PC_U4, AC5_SAP_U1, AC18_PC_U3, AC19_PC_U3,
AC20_PC_U3, AC21_D_U5, AC22_D_U1, AC23_D_U2,
AC24_D_U3, AC25_PC_U3, EXP3_HOS, EXP4_IP, EXP5_IP,
EXP7_PB, EXP8_PB, EXP13_HOS, PH9_HOS, PH19_RD, PM9
“Newly PhD or young staff are work hard for faculty but they
did not have time to do their own career ladder. Leaders have
to protect them. We should have a good mentor for them.”
(AC3_PC_U4)
“The most important factor in the new programme is preceptors
and teacher practitioners. We have teacher practitioners (TP) to
C
hanakit
et
al.BM
C
M
edicalEducation
 (2015) 15:205 
Page
25
of
36
Table 6 Subthemes and supporting quotes within the theme “Concerns” (Continued)
work in hospital as teacher for students and also practice at
training site.” (AC5_SAP_U1)
Good attitude of preceptors AC2_PC_U4, AC8_PC_U4, PH2_HOS, PH6_HOS, PH10_HOS,
PH11_HOS, PH24_HOS
“Training pharmacy students is my responsibility. I am a
pharmacist and I want to make the pharmacy profession
stronger. I am proud to be a preceptor.” (PH24_HOS)
Barriers to be a preceptor (e.g.
workload, time)
AC10_PSc_U5, EXP6_PB, EXP13_HOS, PH25_HOS, PH16_COM,
PH17_RD, ST8, PH021_IP, PH23_PB, PH30_COM
“Being preceptor took a pharmacists’ time.” (EXP13_HOS)
“You want an effective preceptor but you never train us. Is it too
demanding? We already have a high workload.” (PH25_HOS)
“Some of them might not ready to train us because of they did
not have enough time due to their high workload.” (ST8)
Lack of resources (continued) Lack of academic staff in
pharmaceutical care area
AC2_PC_U4, AC4_PC_U3, AC9_SAP_U1, AC10_PSc_U5,
AC21_D_U5, AC25_PC_U3, PM9
“We need real expertise staff in pharm care that they should
have residency degree or board certify but there were a very low
number of this group of academic staff.” (AC21_D_U5)
“Pharmacy graduates in pharm care preferred to work in the
hospital more than to be a lecturer because of high salary and
less stress. We are lack of lecturers and teacher practitioners.”
(PM9)
Lack of practical experience of the
faculty members in both
pharmaceutical care and
pharmaceutical sciences
AC10_PSc_U5, EXP1_COM, EXP2_COM, EXP5_IP, EXP13_HOS,
EXP7_PB
“Most of academic staff works on their research but rarely work
in real practice settings.” (EXP7_PB)
Separate licences Specialty competency should have
separate license
AC12_SAP_U4, EXP1_COM, EXP2_COM, EXP5_PSc, EXP7_PB,
PM1, PM5, PM6
“I encourage the separate license because each specialty
required different competency. For example, within
pharmaceutical care, there should separate into hospital
pharmacist and community pharmacist. IP-PD should not
practice in community pharmacies unless they pass the training
and qualify to work as community pharmacist.”(EXP1_COM)
“Pharmacy professional in each track will be developed. In far
future, there is might be a separation of licensed." (PM1)
“The big issue was relating to license, but at that time, the
council is not ready to give two licenses. As a result, every
university have to change to six-year curriculum with one
license.” (PM5)
“Separate licences seems to narrow down pharmacists’
opportunities to work in various settings. However, we need to
be specialised, which requires different competencies. So, there
should be separate licenses.” (PM 6)
Contrast view
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Table 6 Subthemes and supporting quotes within the theme “Concerns” (Continued)
“I did not agree about separate license. Why we have to close
our opportunity? (EXP5_PSc)
Different programme and two
examination
AC9_SAP_U1, AC10_PSc_U5, AC11_PSc_U5, AC14_SAP_U5,
PM6, PM9
“If they study the difference programmes from first year, they
should have difference license.” (AC9_SAP_U1)
“We will have two pharmacy licensure examinations. The first
examination is for the core competency. The second
examination is for the specialty. Why we have just only one
license?” (PM6)
Competencies of the entry level
pharmacy graduates
EXP1_COM, EXP2_COM, EXP6_PB, EXP13_HOS, PM1, PM3,
PM10
“The confusion in our pharmacy profession that we never talk is
about the in- depth of core competency in the entry level
PharmD programme.” (EXP6_PB)
aAbbreviation
AC_PSc Academic member in pharmaceutical sciences area, AC_PC Academic member in pharmaceutical care area, AC_SAP Academic member in social and administrative pharmacy), AC_D Dean, EXP_HOS Expert in
hospital pharmacy, EXP_COM community pharmacy, EXP_PSc Expert in industrial pharmacy, EXP_PB Expert in public health and consumer protection, EXP_MP Expert in marketing pharmacy, N Nurse, PH_HOS Hospital
pharmacist, PH_COM community pharmacist, PH_IP Industrial pharmacist, PH_PB Pharmacist in public health and consumer protection, PH_MP Pharmacist in marketing pharmacy, PH_RD Pharmacist in Research and
development, PHY Physician, PM Policy maker, PTECH Pharmacy technician, PT_IPD Patient in In-Patient Department, PT_OPD Patient in Out-Patient Department, PUB Public/general population, ST Student, PR Parent,
U1 University1, U2 University2, U3 University3, U4 University4, U5 University5
C
hanakit
et
al.BM
C
M
edicalEducation
 (2015) 15:205 
Page
27
of
36
“PharmD graduates have the skills to approach other
health care providers. They are ready to work after
graduation.” (Pharmacy expert 10)
“PharmD graduates have better skills in patient care.
They are more confident and work well with health
care teams.” (Pharmacist 2, hospital pharmacist)
Physicians and nurses also have positive perceptions to-
wards the 6-year PharmD graduates’ services and thought that
they were effective members of the multidisciplinary team.
“I think it is good to have a pharmacist on ward. We
discuss and share opinions, which are beneficial for
our patients.” (Physician 6)
“The 6-year pharmacy graduates have higher knowledge.
Their views or their critical thinking seem wider or
have more understanding about the concept of a
multidisciplinary team.” (Nurse 1)
Patients also perceived the benefits of pharmacists in the
health care team, which would provide better care for them.
“For the 6-year Pharmacy programme, I think it must
be good. I know that if patients have problems with
medicine they can talk with a pharmacist and the
pharmacist will talk to the doctor for them. It makes
for better care for us.” (Patient 2, Out-patient
Department)
Most policy makers agreed that the transition to a sin-
gle PharmD programme provided the same curriculum
standard throughout the country.
“They all have to be graduates of the six-year programme
and managed in a similar manner.” (Policy maker 3)
Theme 3: Concerns
Interviewees such as hospital pharmacists, other health
care providers and patients, students and parents, and
academic staff in patient care areas were positive overall
regarding the all-PharmD programme, while academic
staff in the pharmaceutical sciences area and industrial
pharmacy experts still had concerns about the curriculum
change and suggestions for its improvement. The detailed
themes and subthemes are presented in Fig. 5. The sub-
themes and supporting quotes are presented in Table 6.
Higher cost of study and value
Some academic staff thought that the policy makers should
consider the increased cost of study due to the extra year.
The students also discussed whether the increased cost of
study was worth it.
“The negative effect is the cost of education to parents
and the government budget of at least six hundred
million baht (£12,253,000 or $18,421,000) a year,
without being able to see the benefit in the short or
long term. Improving pharmacists’ competencies is a
great thing but we have many ways to improve them,
Fig. 5 Theme “Concerns”
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such as via studying or working in real life situations.”
(Academic member 12)
(Note: exchange rates on 08/03/2015; 1 GBP = 48.967
THB and 1 USD =32.570 THB)
“The Pharmacy Council should prepare salary or
compensation for our degree. I heard that they
increased our salary by only 1,000 baht (£20 or $31) a
month compared to the 5-year programme. It is not
worth it to study another one year more, when we have
to spend approximately 100,000 baht (£2042 or
$3070) for this extended year. There should be other
ways to encourage us to work hard and deserve our
salary.” (PharmD student 1)
Some interviewees were concerned that this change
might not deliver an effective pharmacy curriculum that is
suitable for Thai context. They suggested that the new cur-
riculum might cause problems in terms of students’ time
and money and might limit the ability to produce pharma-
cists who could quickly begin to work for Thai society.
“We are not prosperous but we are not very poor either.
We should undertake appropriate education. The issue
is that we would like to follow the western model. We
can find our own way. I do not think six years is the best
study programme in the world.” (Policy maker 10)
“I do not see the benefit of the extended one year or
the value of this change. Why should it not be a
master’s degree instead of a bachelor degree? Parents
have to support the cost for another year and society
has lost a pharmacist for another year.” (Academic
member 16)
Parents of pharmacy students who studied at private
universities said that the cost of their children’s educa-
tion was at least 100,000 baht/year and approximately
500,000 baht (£10,200 or $15,300) in the 6th year; the
total cost was approximately 1,600,000 baht (£32,600 or
$49,100). One father thought that the cost might cause
problems for some families who had low to medium in-
comes, but for him, it was acceptable.
“I think the cost is quite heavy. In cases where we do
not have money, this might be a problem.” (Parent 1)
Another interviewee, from a family with a low income,
thought the cost of education at public university of ap-
proximately 40,000 baht/year (£800 or $1,200), and that
the total cost, which was approximately 300,000 baht
(£6,100 or $9,200), was acceptable. Her son was granted
a scholarship from his faculty and he was very careful
with his money and also had a part time job for his liv-
ing expenses. However, in terms of the cost of education,
even at a public university, it is still a large amount of
money for students’ families.
“The cost is not much harder because he (her son)
helps himself. He got a scholarship from the faculty
and works part-time job with his teacher. When he
comes back home, he rarely asks for money. He needs
only approximately 5,000 baht (£100 or $150) per
month. He is a very good saver. He rarely buys new
clothes.” (Parent 3)
Mismatch between the pharmacy graduates’
competencies and the requirements of the job market
The traditional PharmD programme focused on patient
care but the PharmD curriculum in Thailand is divided
into two main streams: a pharmaceutical care-PharmD
(PC-PD) programme and a pharmaceutical Sciences or
industrial pharmacy-PharmD (IP-PD) programme. How-
ever, both give students the same license to work across
all sectors. There is a general consensus among the in-
terviewees that the aim of the development of a 6-year
programme in Thailand was to improve pharmacy compe-
tencies from generalists to specialists, focusing on pharma-
ceutical care and preparing pharmacy graduates to practice
upon graduation in real workplace settings. Such prepa-
rations would serve to meet the required needs of the
stakeholders. The greatest benefits of producing competent
clinical pharmacists should be to patients, health con-
sumers and Thai society.
However, community pharmacy employers presented
contrasting views. Some argued that the pharmaceutical
care aspect of the PC-PD is very hospital-centred and
the skills acquired are more suited for tertiary and sec-
ondary care settings than primary hospital and commu-
nity pharmacy settings.
“Within the PC-PD programme, it should be separated
into hospital pharmacist and community pharmacist
because they have different required competencies.”
(Pharmacy expert 1, community pharmacy)
“Some faculties taught their PC-PD graduates that they
should work in hospitals only. Students told me that
they were not interested in community pharmacy but
came here because it is only a compulsory rotation.”
(Pharmacy expert 2, community pharmacy)
Pharmacists and pharmacy experts from the consumer
protection area also shared the opinion that the curricu-
lum should prepare pharmacy graduates for primary
care services due to the higher number of primary care
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hospital settings (community hospitals and sub-district
health-promoting hospitals).
On the other hand, the majority of the interviewees
were less positive about the IP-PD graduates meeting
the needs of the market; the number of graduates cur-
rently exceeds the needs of industry, and graduates from
this track often have to pursue career paths in commu-
nity pharmacy, a sector for which they are not prepared.
“Most of the pharmaceutical sciences students worked
in community pharmacies because they got higher
salaries than industrial plants but they were not well
trained.” (Academic member 11)
In addition, this view is also shared by participants
from the industrial sector who believe that IP-PD gradu-
ates lack the research skills required for the research and
development industry and often prefer to employ PhD
holders of non-pharmacy science backgrounds.
“The private sector hired graduates from other areas
such as scientists who have a PhD degree. If you
compare pharmacists who have a bachelor's degree
and scientists who have a PhD, pharmaceutical
companies need PhDs more than pharmacists because
they have more experience in R&D.” (Academic
member 10)
In contrast, some policy makers perceived that the
PharmD graduates will be more skilled in research and
development, which might meet the needs of employers.
There are plenty of opportunities to create the curriculum
and make a difference for graduates, but this depends on
the cooperation of the leader, dean and academic staff
in the pharmaceutical sciences area to prepare this new
curriculum.
“Job markets are still available but we have to open
new markets, such as areas in vaccines, blood
substitutes, nanotechnology, in herbal medicine.
Faculty should move to design our graduates.” (Policy
maker 5)
To fulfil the needs of the IP-PD graduates’ competency
for the area of research and development, an integrated
PharmD-PhD programme was developed at one of the
universities in Thailand, aiming to prepare highly com-
petent graduates to study in PhD programmes. This is
an interesting programme designed to suit the needs of
the pharmacy or pharmaceutical industry.
Lack of preceptor and training sites
The crucial issue for the transition to an all-PharmD
programme is providing a sufficient number of qualified
PharmD preceptors. The new PharmD curriculum has a
four-fold increase in the number of hours for practice
training compared with the BPharm programme. How-
ever, the number of qualified preceptors remains the
same. The PECT tried to establish a preceptor develop-
ment programme to prepare for this change but the ma-
jority of the stakeholders perceived that this was still not
enough.
“It increases the load of preceptors, of which there are
still the same number. Every faculty is competing.”
(Academic member 22)
Stakeholders felt there were benefits for institutions if
they are offered as training sites (e.g., contributing to the
pharmacy profession, updating preceptors’ knowledge
and skills, having highly competent academic members
who are able to empower preceptors and enhance train-
ing sites and opportunities to recruit well-performing
pharmacy students).
“Training pharmacy students is my responsibility. I
am a pharmacist and I want to make the pharmacy
profession stronger. I am proud to be a preceptor.”
(Pharmacist 24)
However, the majority of the interviewees had common
concerns regarding the insufficient quantity and quality of
preceptors. Stakeholders’ perceived barriers towards for-
mal preceptor preparation, such as the workload (e.g.,
high routine workload of the preceptors, lack of time/
money/management staff/space), inadequate role models,
the need for more recognition and support from adminis-
trators regarding preceptors’ roles, training sites requiring
standardisation and quality assurance, career progression
as preceptors and a reward system for their clerkship
workload, the need to put in place a preceptor develop-
ment programme and the establishment of an active
memorandum of understanding (MoU)/long term com-
mitment between training sites and universities.
“You want an effective preceptor but you never train
us. Is it too demanding? We already have a high
workload.” (Pharmacist 25)
One employer in industrial pharmacy thought that the
training patterns in the pharmaceutical sciences area should
be reconsidered and needed changing. Academics who have
more training in research should teach students about
pharmaceutical sciences in the universities. This strategy
might be better than sending students to be trained in in-
dustry, which has a limited number of preceptors, insuffi-
cient space and too few training sites. Of more concern,
some trainers who were non-pharmacists in industrial
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pharmacy settings were diploma graduates who wondered
about their qualification to teach pharmacy students.
“Increasing to six years and releasing students out into
the real world to find experience for themselves is not
the right way. Lecturers or master's degree students
should be trained, and their experience will transfer to
students. At least 20 students will be trained at each
site, but the site employs only one pharmacist.” (Policy
maker 4)
Lack of practical experience of the faculty members
Deans and policy makers had planned to increase the
number of instructors in the pharmaceutical care area
due the lack of pharmacy practice staff within academic
institutions. Unfortunately, they found it was difficult to
recruit pharmacy graduates to work as instructors in
pharmaceutical care within academic institutions be-
cause they preferred to work in other pharmacy practice
areas such as hospital or community pharmacy settings
due to higher salaries and less stressful environments.
“Pharmacy graduates in pharm care preferred to work
in the hospital more than to be a lecturer because of
higher salary and less stress.” (Policy maker 9)
Highly performing academic staff in the pharmaceutical
care area who have graduated from a pharmacotherapy
residency programme are scarce and are in great demand.
They also act as role models for PharmD students. Senior
academics and experts said that they work very hard and
that faculty have to take care of them and not let them be-
come burnt out by the high workload.
Separate licences
Previously there has only been one type of license for
Thai pharmacists across all pharmacy practice settings.
Pharmacy graduates from both the BPharm and PharmD
programmes have been required to take the same na-
tional licensure examination. However, the PharmD stu-
dents who start their pharmacy education in and after
2015 will have to take two pharmacy licensure examina-
tions: the first examination is for pharmacy core compe-
tency at the end of their fourth year and the second
examination is for their specialised competency at the
end of their sixth year. The examination had to be sepa-
rated into two different examinations because those two
tracks were very different in terms of their specialties
(e.g., knowledge content, clerkship experiences and spe-
cialised skills) but they still have the same license. Separ-
ate licenses were mentioned in earlier stages of decision
making.
Some faculty members were concerned about the vi-
sion of the Thai pharmacy profession. If it aimed to
move practitioners from being generalists to specialist
pharmacists, different types of pharmacy licenses should
be offered. Some policy makers advised to offer separate
pharmacy licences in the future, and pharmacists should
not work across the professional pharmacy tracks; for in-
stance, pharmacy graduates in pharmaceutical industrial
should not work in community pharmacy because they
may not have sufficient competency. Pharmacy profes-
sionals in specific areas should work only in their area
because this represents a commitment to the develop-
ment of the pharmacy profession in those specific areas.
They might cross over to other tracks, but there should
be a system to assess their competencies (e.g., taking a
training course or continuation of their pharmacy educa-
tion) to ensure the delivery of good pharmacy practice
and to meet the required standard in each practice area.
“Separate licences seems to narrow down pharmacists’
opportunities to work in various settings. However, we
need to be specialised, which requires different
competencies. So, there should be separate licenses.”
(Policy maker 6)
On the other hand, some academics said that there
should be only one license. They thought that the advan-
tages were as follows: an opportunity to work in various
areas of pharmacy practice, as in the past, and one license
would, or at least could, unite the pharmacy profession.
The situation was frequently compared to the doctor’s li-
cense: a doctor has only one license but different doctors
might have different specialties.
Discussion
In the past three decades, the roles of pharmacists glo-
bally have changed dramatically. Pharmacists responsibility
are not merely in compounding or dispensing medicines
but in providing a professional role in patient care [7]. The
main limitation to developing advanced clinical roles is a
lack of clinical skills. The genesis of the 6-year PharmD
programme in Thailand began from the needs of pharma-
cists who would like to develop themselves to provide a
better standard of patient care. It was similar to the adop-
tion of the PharmD in the US, Canada and South Korea
that was led by the needs of clinical pharmacists who had
higher competency in patient care [10, 89, 90]. The
PharmD programme is the model for the pharmaceutical
care programmes employed by many other countries [11].
It has been mentioned in many countries who have
adopted, or plan to [8] adopt, this programme to produce
pharmacy graduates who have high levels of knowledge
and skill in pharmaceutical care and who work well to-
gether with other health care providers [7, 91, 92].
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The strong cooperative network of PECT and the US-
Thai consortium for the development of pharmacy edu-
cation in Thailand appeared to be the most important
influence on the development of the PharmD programme
in Thailand [18, 20–22]. Another important influence is
the regulatory body that has the authority to make the
policy a reality. The process of the ‘all-PharmD’
programme has also been mandated by the authorities in
many countries (e.g., Canada, Japan, South Korea) [7, 10, 93].
Interviewees in the pharmaceutical care area appeared
to welcome the 6-year PharmD programme due to this
new programme being a step-up process for the pharmacy
profession that has the same curriculum duration as the
MD or DDS degree, filling the gap left by the 5-year
BPharm programme, which involved less practice and
might produce a graduate who had insufficient competen-
cies to practice on the job market today. This benefit was
also mentioned in the adoption of a 6-year pharmacy
programme in the US and South Korea [8, 94]. Another
important benefit is that PharmD graduates are ready to
work, with little support, following graduation and thus
are becoming increasingly common and valued in the
Thai health system [21, 95, 96].
Thailand is among the world’s middle income coun-
tries. An average monthly income per household in the
whole Kingdom of Thailand in 2013 was 25,194 baht
(£477 or $746) [97]. The expenditure for one full time
student at faculty of pharmacy of a public university was
140,000 baht per year (£2,700 or $4,100) [98]. The pro-
posed increased average cost to cover the additional one
year in the PharmD programme was 600,000,000 baht
(£11,590,000 or $17,780,000) [48]. Some parents in this
study and others reported concerns about the cost of
pharmacy education, which can be a major financial in-
vestment. However, they were prepared to support their
students or seek other financial support such as grants,
scholarships or government-sponsored student loan schemes
[99–101]. Some academic staff were concerned that the in-
crease of an extra year of education would limit the ability of
students to start earning an income and might be a burden
for students, their families and the government. This study
noted the same considerations as another study [100, 101],
in that the curriculum should be designed to deliver an
effective education that is able to produce competent
pharmacy graduates while also saving money and time.
Some students were concerned about the fact that tu-
ition have increased fees but salaries and available posi-
tions have not increased, which was a similar concern
in the US [100]. Cain et al. suggested that it is neces-
sary to ensure that excellent students are not deterred
from pharmacy education by concerns about insurmount-
able costs or debt after graduation [100].
There were also concerns about the insufficient quan-
tity and quality of trained preceptors, multidisciplinary
learning and practice in training sites, quality assurance,
support and recognition from administration, and a pre-
ceptor development programme [102, 103].
The Thai and Pakistani PharmD curricula are both
different from the US PharmD [37, 104]. They were
adapted to meet the country’s needs by including clin-
ical tracks and industrial pharmacy tracks. In 2012, the
percentages of Thai pharmacists in each sector were as
follows: hospital (40 %), pharmacy marketing (22 %),
community pharmacy (17 %), pharmaceutical industry
(10 %), consumer protection (6 %) and education (5 %)
[5, 105]. Hence, a single pattern pharmacy programme
might not be able to produce all of the competencies
needed in all of the pharmacy practice areas [3, 5]. This
study found a mismatch between pharmacy graduates’
competencies and the requirements of the job market.
Competencies required for an industrial pharmacist are
completely different from a pharmacist who provides
pharmaceutical care in tertiary hospitals or from the
community pharmacist who provides home health care
and health promotion [23, 37]. It is interesting that most
pharmaceutical sciences track graduates appeared to work
in the community pharmacy setting. Academics should
seriously revise the content and practical experiences in
the curriculum to meet the needs of graduates and Thai
society [1, 3, 106]. Faculties should coordinate with the
various Thai pharmacy associations, such as the Associ-
ation of Hospital Pharmacy (Thailand), Community Phar-
macy Association (Thailand), Thai Industrial Pharmacist
Association, and Marketing Pharmacy Association of
Thailand to update the competencies required by phar-
macy graduates. Faculties must adapt more quickly (their
vision, academic workforce planning, providing facilities,
preceptor co-development programme, legal consider-
ations affecting pharmacists’ roles and responsibilities) to
support the needs of society and rapidly changing health
care systems [1, 7, 39, 93, 104].
This study might be of interest to faculties and policy
makers to develop pharmacy curricula and national phar-
macy competency standards to produce future pharmacy
practitioners and pharmaceutical scientists who are ready
to work to deliver high-quality services to patients and the
public and also consider national pharmacy workforce
planning to propose numbers of prospective pharmacy
students in different specialties.
The limitation of this study lies in the volunteer partici-
pants. Some informants who were involved in the transi-
tion process did not participate in this study. It is unclear
whether there are differences in the experience and per-
ceptions of the two groups of informants: those who de-
cided to participate and those who did not participate in
this study. The findings might be influenced by some par-
ticipants’ enthusiasm about this transition [107]. However,
this study attempted to include a maximum variation of
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participants [65], including those who agree and do not
agree with this curriculum change. Another limitation is
that the transition to an all-PharmD programme is still at
an early stage. The first cohort of “all-PharmD students”
graduated in March 2015, so the benefit or merit of this
transition in terms of both education and services might
not be clearly visible at the time of this study (2013). More
prolonged and in-depth study is needed to determine the
impact of the transition on students' competencies, pro-
fessional performance in pharmacy services and the satis-
faction of employers and society [107].
Conclusions
This is the first study of its kind to highlight the issues
surrounding the transition to the 6-year PharmD
programme in Thailand, which was initiated due to the
need for higher levels of competency for the nation’s
pharmacists. The transition was influenced by many
factors (e.g., the global trend towards providing patient
care services, cooperation of four pharmacy faculties
and the Ministry of Public Health to develop a founda-
tion for clinical pharmacy activities in hospital settings,
the US-Thai consortium for the development of phar-
macy education, which founded by the PECT, and the
establishment of the PCT). Many participants perceived
benefits from the new pharmacy curriculum; for example,
the PharmD graduates will acquire an advanced phar-
macy professional degree, improve pharmacy competen-
cies from generalists to specialists, will be ready to work
as pharmacists after graduation, will understand health
care teams and will provide a high quality of patient care.
However, some participants were concerned regarding the
curriculum change, such as regarding the higher costs of a
longer period of time for study, the mismatch between the
pharmacy graduates’ competencies and the job market’s
needs, the need to consider designing the curriculum to
suit pharmacy services in other areas in addition to ter-
tiary care settings (e.g., primary care, community phar-
macy, consumer protection), and that the number of
graduates in IP-PD might exceed the needs of industry,
leading them to pursue career paths in community phar-
macy for which they were not well prepared. The most
crucial concerns are about the insufficient preceptors and
training sites, the lack of practical experience of the faculty
members and issues related to separate licenses due to the
differences in graduates’ specialties. Although most of the
respondents accepted the need to go forward to the 6-year
PharmD programme, the design of an effective curricular,
providing a sufficient number of qualified PharmD pre-
ceptors, determining certain competencies of pharmacists
in different practices and monitoring the quality of phar-
macy education still need to be addressed in this transition
stage of pharmacy education in Thailand.
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